Dasatinib and nilotinib for imatinib-resistant or -intolerant chronic myeloid leukaemia: a systematic review and economic evaluation.

BACKGROUND: Chronic myeloid leukaemia (CML) is a form of cancer affecting the blood, characterised by excessive proliferation of white blood cells in the bone marrow and circulating blood. In the UK, an estimated 560 new cases of CML are diagnosed each year. OBJECTIVES: The purpose of this study was...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Health Technol Assess
Autors principals: Rogers, G, Hoyle, M, Thompson Coon, J, Moxham, T, Liu, Z, Pitt, M, Stein, K
Format: Artigo
Idioma:Inglês
Publicat: NIHR Journals Library 2012
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4781389/
https://ncbi.nlm.nih.gov/pubmed/22551803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta16220
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars